Moving From Alteplase to Tenecteplase for Acute Ischemic Stroke

特奈特普酶 医学 改良兰金量表 组织纤溶酶原激活剂 溶栓 纤溶剂 脑出血 冲程(发动机) 内科学 蛛网膜下腔出血 缺血性中风 心脏病学 缺血 心肌梗塞 机械工程 工程类
作者
Ahmed Koriesh,Michael Liu,Waleed Brinjikji,James P. Klaas,Deena M. Nasr,Zafer Keser
出处
期刊:The Neurologist [Lippincott Williams & Wilkins]
卷期号:29 (1): 50-53 被引量:5
标识
DOI:10.1097/nrl.0000000000000524
摘要

OBJECTIVES: Tenecteplase is a fibrin-specific plasminogen activator that has shown promising results in the treatment of acute ischemic stroke. Tenecteplase has been suggested to reduce door-to-needle time and to increase the rate of spontaneous recanalization. In February 2021, Mayo Clinic Health System switched to Tenecteplase as the standard thrombolytic therapy for acute ischemic stroke. METHODS: In this center-based observational cohort study, we present clinical characteristics and outcomes of patients with acute ischemic stroke treated with tenecteplase between February 2021 and May 2022 compared with alteplase treatment between September 2019 and February 2021. We used descriptive and comparative statistics. RESULTS: Baseline characteristics were comparable between the groups. The incidence of symptomatic intracerebral hemorrhage was significantly less among the tenecteplase group (0.65% vs. 5%, P =0.027). Both groups had a similar door-to-needle time [55 (IQR 30.5) vs. 57 (IQR 38) in the tissue plasminogen activator group, P =0.395]. Spontaneous partial or complete recanalization was more commonly observed in the tenecteplase group (10.4% vs. 1.4%, P =0.038). Mechanical thrombectomy for large vessel occlusion was deferred due to marked clinical improvement more commonly in tenecteplase (6.3% vs. 1.4%); however, this difference was not statistically significant. Ninety-day modified Rankin Scale did not show a significant difference between the groups. CONCLUSION: Tenecteplase use as the thrombolytic agent in acute ischemic stroke was associated with lower rates of symptomatic intracranial hemorrhage, higher rates of spontaneous recanalization, but similar door-to-needle time and 90-day modified Rankin Scale as compared with tissue plasminogen activator.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Nole的应助被欢乐的兔子采纳,获得10
1秒前
自觉新竹发布了新的文献求助10
1秒前
秋风的应助被土制陶瓷采纳,获得10
1秒前
脑洞疼的应助被大左采纳,获得10
2秒前
晚风发布了新的文献求助10
2秒前
zik发布了新的文献求助10
2秒前
超级无敌的应助被雪山大地采纳,获得10
2秒前
2秒前
在水一方的应助被顺利采纳,获得10
3秒前
嵇老五发布了新的文献求助10
4秒前
英姑的应助被开心德地采纳,获得10
6秒前
满意妙梦完成签到,获得积分10
7秒前
洁净雅彤发布了新的文献求助10
8秒前
笨笨米卡发布了新的文献求助200
8秒前
8秒前
10秒前
wg发布了新的文献求助10
10秒前
哇啦的应助被yang采纳,获得10
11秒前
哇啦的应助被yang采纳,获得10
11秒前
哇啦的应助被yang采纳,获得10
11秒前
罗春的应助被yang采纳,获得10
11秒前
哇啦的应助被yang采纳,获得10
11秒前
深情安青的应助被yang采纳,获得10
11秒前
orixero的应助被yang采纳,获得10
12秒前
思源的应助被yang采纳,获得10
12秒前
TravelingLight完成签到,获得积分10
12秒前
FashionBoy的应助被yang采纳,获得10
12秒前
科研通AI6.4的应助被yang采纳,获得10
12秒前
orixero的应助被OK采纳,获得10
12秒前
JamesPei的应助被李小刚采纳,获得10
13秒前
14秒前
lytelope完成签到,获得积分10
14秒前
Winnie发布了新的文献求助10
15秒前
水煮电吹风的应助被雪山大地采纳,获得10
15秒前
科研通AI2S的应助被开心德地采纳,获得10
15秒前
15秒前
17秒前
晚风发布了新的文献求助10
18秒前
Orange的应助被科研通管家采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188451
求助须知:如何正确求助?哪些是违规求助? 9576286
关于积分的说明 21846376
捐赠科研通 7786514
什么是DOI,文献DOI怎么找? 3435343
关于科研通互助平台的介绍 2559618
邀请新用户注册赠送积分活动 2482322